The amino-terminal ectodomain of thyrotropin (TSH) receptor (TSHR) is heavily glycosylated with asparagine-linked (N-linked) oligosaccharides. The present studies were designed to evaluate how acquisition and processing of N-linked oligosaccharides play a role in the functional maturation of human TSHR. A glycosylation inhibitor tunicamycin, which inhibits the first step of N-linked glycosylation (acquisition of N-linked oligosaccharides), and a series of mutant Chinese hamster ovary (CHO)-Lec cells defective in the different steps of glycosylation processing were used. Inhibition of acquisition of N-linked oligosaccharides by tunicamycin treatment in CHO cells stably expressing TSHR produced nonglycosylated TSHR, which was totally nonfunctional. In contrast, all of the TSHRs synthesized in mutant CHO-Lec1, 2, and 8 cells (mannose-rich, sialic acid-deficient, and galactose-deficient oligosaccharides, respectively) bound TSH and produced cAMP in response to TSH with an affinity and an EC 50 similar to those in TSHR expressed in parental CHO cells (CHO-TSHR; sialylated oligosaccharides). However, Lec1-TSHR and Lec2-TSHR were not efficiently expressed on the cell surface, whereas the expression levels of Lec8-TSHR and CHO-TSHR were essentially identical. All of the TSHRs expressed in CHO-Lec cells cleaved into two subunits. Finally, anti-TSHR autoantibodies from Graves' patients interacted with all of the TSHRs harboring different oligosaccharides to a similar extent. These data demonstrate that acquisition and processing of N-linked oligosaccharides of TSHR appear to be essential for correct folding in the endoplasmic reticulum and for cell surface targeting in the Golgi apparatus. We also show that complex type carbohydrates are not crucially involved in the interaction of TSHR with TSH and anti-TSHR autoantibodies.The receptors for glycoprotein hormones (thyrotropin receptor (TSHR), 1 lutropin receptor (LHR), and follitropin receptor (FSH)) are members of a subfamily of G protein-coupled receptors, characterized by an extremely large amino-terminal extracellular domain, which is the high affinity binding site for the respective ligands (1, 2) and is, in the case of TSHR, the primary autoantigen in autoimmune thyroid disease, including Graves' disease (1). Like many other secreted and cell surface proteins, these receptors undergo a series of posttranslational modifications such as disulfide bonding (1), glycosylation (3-9), palmitoylation (10, 11), and proteolytic cleavage (subunit formation in TSHR) (12-14), many of which appear to play roles in protein maturation and/or intracellular trafficking. In human TSHR, the receptor ectodomain has asparaginelinked (N-linked) oligosaccharides, which represent 30ϳ40% of its molecular weight (15). Earlier studies with in vitro sitedirected mutagenesis suggest that, among six potential Nlinked glycosylation sites, the first (amino acid 77) and third (amino acid 113) glycosylation sites are essential for the cell surface expression and function of the full-length TSHR (16)....